NDC 50458-607 – Invega Trinza
Paliperidone Palmitate 410 mg/1.32mL · Injection, Suspension, Extended Release · Intramuscular
Product NDC50458-607
Product details
- Brand name
- Invega Trinza
- Generic name
- paliperidone palmitate
- Labeler
- Janssen Pharmaceuticals, Inc
- Dosage form
- Injection, Suspension, Extended Release
- Route
- Intramuscular
- Marketing category
- NDA · NDA207946
- Marketed since
- May 19, 2015
- Listing expires
- December 31, 2026
- Pharmacologic class
- Atypical Antipsychotic
Active ingredients
- Paliperidone Palmitate 410 mg/1.32mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 50458-607-01 | 1 SYRINGE in 1 KIT (50458-607-01) / 1 mL in 1 SYRINGE | May 19, 2015 |
Other Invega Trinza products
- 50458-606 Paliperidone Palmitate 273 mg/.88mL · Injection, Suspension, Extended Release · Janssen Pharmaceuticals, Inc
- 50458-608 Paliperidone Palmitate 546 mg/1.75mL · Injection, Suspension, Extended Release · Janssen Pharmaceuticals, Inc
- 50458-609 Paliperidone Palmitate 819 mg/2.63mL · Injection, Suspension, Extended Release · Janssen Pharmaceuticals, Inc